ALS Research

Home/ALS Research

Healey ALS Platform Trial

The HEALEY ALS Platform Trial is enrolling people living with Amyotrophic Lateral Sclerosis(ALS) to test the efficacy of multiple investigational products. The Platform Trial is designed to decrease the time it takes to test new potential therapies and increase access to research forpeople living with ALS. One of the innovative features of the Platform Trial is that enrollment will continue as more investigational products are added. For more information about the Healey ALS Platform trial, see this article for links to general information and for FAQs about the trial.  

2023-09-29T02:41:52+00:00September 29th, 2023|

Big News: Approval of AMX0035 by FDA Advisory Committee

The FDA advisory committee recently approved the use of AMX0035 for the treatment of ALS. Presented with the robustness of new evidence, the committee reversed their March 2022 vote overwhelming by a 7-2 vote. The ALS Association has publicly thanked both the FDA advisory committee and the entire ALS community for their hard work and advocacy. Read Full Article

2023-09-29T02:19:58+00:00September 12th, 2022|

Research on Chinese Herbal Prescription for ALS Treatment

Read this article from the National Library of Medicine to learn about a case of ALS patient using modified Dihuang Yinzi (DHYZ), a classical traditional Chinese medicine (TCM) prescription.  This person has survived 12 years with significant improvement in bulbar paralysis.

2022-07-26T21:23:41+00:00May 26th, 2016|